Vaccines for Porcine Diseases

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 13

Special Issue Editors


E-Mail Website
Guest Editor
Guangdong Province Key Laboratory of Livestock Disease Prevention, Guangdong Provincial Observation and Research Station for Animal Disease, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Baishigang, Wushan Street, Tianhe District, Guangzhou 510640, China
Interests: animal molecular virology; development and standardization of pathogen and antibody detection methods; recombinant live vector vaccines and biosafety evaluation

E-Mail Website
Guest Editor
Molecular Biomedical Sciences Department, and Comparative Medicine Institute, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA
Interests: immunology; animal models; vaccine development; molecular biology

Special Issue Information

Dear Colleagues,

Porcine diseases continue to threaten global animal health, food security, and economic stability. While vaccination remains the cornerstone of disease prevention and control, traditional platforms often face limitations in terms of safety, efficacy, and adaptability to evolving pathogens. Recent breakthroughs in biotechnology in addition to deepened insights into ‌host–pathogen interactions‌ and ‌porcine immunology‌ are critical to optimizing vaccine performance. To address urgent gaps in porcine vaccinology, we invite you to contribute to this Special Issue, which emphasizes interdisciplinary innovation to combat current and emerging threats. It aligns with Vaccines’ mission to advance high-impact research on vaccine design, immune mechanisms, and clinical applications. By fostering collaboration among researchers, veterinarians, and industry experts, this collection aims to accelerate the development of sustainable solutions for porcine disease control. We welcome the submission of original research articles and reviews. Research areas may include (but are not limited to) the following: (1) Next-generation vaccine development—mRNA, DNA, or viral-vectored vaccines; multivalent vaccines for cross-protection against diverse strains; and structural biology-guided antigen design. (2) ‌Immune mechanisms and adjuvant innovation novel delivery routes, as well as adjuvant, cellular, humoral, and mucosal immunity. (3) ‌Pathogen-specific challenges—virulence factors and vaccine candidate targets, as well as strategies for universal vaccine design. We look forward to receiving your contributions.

Dr. Xiaohu Wang
Dr. Lizette M. Cortes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine development
  • immune mechanisms
  • adjuvants
  • global animal health
  • porcine diseases
  • vaccine candidate targets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop